// App-Quantinova.ai

9570 : Prognosticators of first line treatment for metastatic uveal melanoma (MUM).

Researchers

Presenter

  • Mathew Nicholas

Principal Investigators

  • Leila Khoja

  • David Hogg

  • Ian Quirt

  • Marcus O. Butler

  • Anthony M. Joshua

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Uveal melanoma

  • Solid malignancies

Biomarkers

  • Alkaline phosphatase

  • Neutrophil lymphocyte ratio

  • Lactate dehydrogenase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved